Latest News & Features
Asia
In India, a non-profit organisation and an advocacy group have united to take on a patent covering pibrentasvir, part of the drug combination that forms AbbVie’s hepatitis C product Mavyret. 26 July 2018
Americas
Donald Trump was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 26 July 2018
Big Pharma
Earlier today, the Court of Justice of the European Union clarified when a product is ‘protected by a basic patent’ within the meaning of article 3(a) of the SPC regulation. 25 July 2018
Americas
California-based Sangamo Therapeutics has acquired biotech company TxCell for approximately €72 million. 25 July 2018
Americas
Bernard Tyson was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 25 July 2018
Africa
Tedros Ghebreyesus was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 24 July 2018
Americas
The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines. 24 July 2018
Americas
The US Court of Appeals for the Federal Circuit’s ruling that tribal sovereign immunity doesn’t apply in inter partes review proceedings has sparked questions over state protections at the Patent Trial and Appeal Board. 24 July 2018
Asia
Sung Yunmo was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 24 July 2018
Americas
Biopharmaceutical company Kite, a subsidiary of Gilead, and immunotherapy development company Gadeta announced on Thursday, July 19 that they have entered into a strategic collaboration to produce cancer therapies. 23 July 2018